Influence of epinephrine, propranolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 10, 1997, Pages 1102-1114

  Shimizu, Wataru ^a,b   Kamakura, Shiro ^a   Kurita, Takashi ^a   Suyama, Kazuhiro ^a   Aihara, Naohiko ^a   Shimomura, Katsuro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Dispersion; Epinephrine; Long QT syndrome; Recovery time

Indexed keywords

ADRENALIN; PROPRANOLOL;

ADULT; ALPHA ADRENERGIC STIMULATION; ARRHYTHMOGENESIS; ARTICLE; BETA ADRENERGIC STIMULATION; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM PACING; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; MALE; PRIORITY JOURNAL;

EID: 0030863127     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb00996.x     Document Type: Article

References (36)

1. Schwartz PJ: Idiopathic long QT syndrome: Progress and questions. Am Heart J 1985;109:399-411.
2. Jackman WM, Friday KJ, Anderson JL, et al: The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-172.
3. Zipes DP: The long QT syndrome: A rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991;84:1414-1419.
4. Moss AJ, Schwartz PJ, Crampton RS, et al: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144.
5. Schwartz PJ, Locati EH, Napolitano C, et al: The long QT syndrome. In Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Second Edition. WB Saunders Co., Philadelphia, 1995, pp. 788-811.
6. Eldar M, Griffin JC, Abbott JA, et al: Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-607.
7. Moss AJ, Liu JE, Gottlieb S, et al: Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-1529.
8. Millar CK, Kralios FA, Lux RL: Correlation between refractory periods and activation-recovery intervals from electrograms: Effects of rate and adrenergic interventions. Circulation 1985;72:1372-1379.
9. Haws CW, Lux RL: Correlation between in vivo transmembrane action potential durations and activation-re- covery intervals from electrograms: Effects of interventions that alter repolarization time. Circulation 1990;81:281-288.
10. Shimizu W, Kamakura S, Ohe T, et al: Diagnostic value of recovery time measured by body surface mapping in patients with congenital long QT syndrome. Am J Cardiol 1994;74:780-785.
11. Schwartz, PJ, Moss AJ, Vincent CM, et al: Diagnosticcriteria for the long QT syndrome: An update. Circulation 1993;88:782-784.
12. Watanabe T, Toyama J, Toyoshima H, et al: A practical microcomputer based mapping system for body surface, precordium, and epicardium. Comput Biomed Res 1981;14:341-354.
13. Ambroggi LD, Bertoni T, Locati E, et al: Mapping of body surface potentials in patients with the idiopathic long QT syndrome. Circulation 1986;74:1334-1345.
14. Ambroggi LD, Negroni MS, Monza E, et al: Dispersion of ventricular repolarization in the long QT syndrome. Am J Cardiol 1991;68:614-620.
15. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995;92:3381-3386.
16. Brachmann J, Scherlag BJ, Rosenshtraukh LV, et al: Bradycardia-dependent triggered activity: Relevance to drug-induced multiform ventricular tachycardia. Circulation 1983;68:846-856.
17. Roden DM, Hoffman BF: Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers: Relationship to potassium and cycle length. Circ Res 1985;56:857-867.
18. Bonatti V, Rolli A, Botti G: Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias. Eur Heart J 1983;4:168-179.
19. Jackman WM, Szabo B, Friday KJ, et al: Ventricular tachyarrhythmias related to early afterdepolarizations and triggered firing: Relationship to QT interval prolongation and potential therapeutic role for calcium channel blocking agents. J Cardiovasc Electrophysiol 1990;1:170-195.
20. Shimizu W, Ohe T, Kurita T, et al: Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 1991;84:1915-1923.
21. Shimizu W, Ohe T, Kurita T, et al: Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995;26:1299-1309.
22. Linker NJ, Camm AJ, Ward DE: Dynamics of ventricular repolarization in the congenital long QT syndromes. Br Heart J 1991;66:230-237.
23. Priori SG, Napolitano C, Diehl L, et al: Dispersion of the QT interval: A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-1689.
24. Surawicz B: Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989;14:172-184.
25. Shimizu W, Antzelevitch C: Sodium channel block with mexiletine is effective in reducing transmural dispersion of repolarization and preventing torsade de pointes in LQT2 as well as LQT3 models of the long QT syndrome. Circulation 1997: (In press).
26. Ben-David J, Zipes DP: Differential response to right and left ansae suhclaviae stimulation of early afterdepolarizations and ventricular tachycardia induced by cesium in dogs. Circulation 1988;78:1241-1250.
27. Curran ME, Splawski I, Timothy KW, et al: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
28. Wang Q, Shen J, Splawski I, et al: SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
29. Wang Q, Curran ME, Splawski I, et al: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet 1996;12:17-23.
30. Kr potassium channel. Cell 1995;81:299-307.
31. K, potassium channel. Nature 1996;384:80-83.
32. Ks cardiac potassium current. Nature 1996;384:78-80.
33. Moss AJ, Zareba W, Benhorin J, et al: ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.
34. Dausse E, Berthet M, Denjoy I, et al: A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol 1996;28:1609-1615.
35. Malfatto G, Beria G, Sala S, et al: Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 1994;23:296-301.
36. Lehmann MH, Suzuki F, Fromm BS, et al: T-wave "humps" as a potential electrocardiographic marker of the long QT syndrome. J Am Coll Cardiol 1994;24:746-754.